Health10 months ago
Acadia Pharmaceuticals Delays UK Launch of Rett Syndrome Drug
Acadia Pharmaceuticals has announced an indefinite delay in its plans to seek approval for its Rett syndrome drug, Daybue, in the United Kingdom. This decision stems...